Doberstein Stephen K
SVP & Chief Scientific Officer at NKTR
- Sold, on record
- $30.7M
- Dollars the filings state
- Form 4 sales
- 17
- Latest Aug 16, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NKTRNEKTAR THERAPEUTICSSVP & Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale NKTRUnusualNov 8 2017
Sold 396,323 shares at $29.00 ($11.5M)
Doberstein Stephen K, SVP & Chief Scientific Officer
Sold 92.7% of holdings ($12.4M position)31,102 shares left296.6x usual sizeFiling
- 2 Form 4 sale NKTRPlan not statedFeb 16 +100 days
Sold 2,426 shares at $82.94 ($201k)
Doberstein Stephen K, SVP & Chief Scientific Officer
Sold 3.5% of holdings ($5.8M position)67,394 shares left1.6x usual sizeFiling
- 3 Form 4 sale NKTRUnusualApr 9 +52 days
Sold 160,000 shares at $93.06 ($14.9M)
Doberstein Stephen K, SVP & Chief Scientific Officer
Sold 70.4% of holdings ($21.2M position)67,394 shares left94.1x usual sizeFiling
- 4 Form 4 sale NKTRPlan not statedMay 16 +37 days
Sold 3,435 shares at $83.39 ($286k)
Doberstein Stephen K, SVP & Chief Scientific Officer
Sold 5.1% of holdings ($5.6M position)63,959 shares left2x usual sizeFiling
- 5 Form 4 sale NKTRPlan not statedNov 16 +184 days
Sold 4,524 shares at $38.25 ($173k)
Doberstein Stephen K, SVP & Chief Scientific Officer
Sold 5.4% of holdings ($3.2M position)78,734 shares left1.5x usual sizeFiling
- 6 Form 4 sale NKTRPlan not statedFeb 19 +95 days
Sold 3,310 shares at $42.39 ($140k)
Doberstein Stephen K, SVP & Chief Scientific Officer
Sold 3.2% of holdings ($4.4M position)99,374 shares left0.7x usual sizeFiling
- 7 Form 4 sale NKTRPlan not statedMay 16 +86 days
Sold 3,461 shares at $31.37 ($109k)
Doberstein Stephen K, SVP & Chief Scientific Officer
Sold 3.5% of holdings ($3.1M position)95,913 shares left1x usual sizeFiling
- 8 Form 4 sale NKTRPlan not statedAug 16 +92 days
Sold 3,245 shares at $18.15 ($59k)
Doberstein Stephen K, SVP & Chief Scientific Officer
Sold 3.4% of holdings ($1.7M position)92,668 shares left0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (17)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2019 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 3,245 | $59k | 3.4% | Plan not stated | SEC |
| May 16, 2019 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 3,461 | $109k | 3.5% | Plan not stated | SEC |
| Feb 19, 2019 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 3,310 | $140k | 3.2% | Plan not stated | SEC |
| Nov 16, 2018 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 4,524 | $173k | 5.4% | Plan not stated | SEC |
| May 16, 2018 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 3,435 | $286k | 5.1% | Plan not stated | SEC |
| Apr 9, 2018 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 160,000 | $14.9M | 70.4% | Unusual | SEC |
| Feb 16, 2018 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 2,426 | $201k | 3.5% | Plan not stated | SEC |
| Nov 8, 2017 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 396,323 | $11.5M | 92.7% | Unusual | SEC |
| Oct 5, 2017 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 43,677 | $1.1M | 58.4% | Unusual | SEC |
| Aug 16, 2017 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 1,701 | $33k | 5.2% | Plan not stated | SEC |
| May 16, 2017 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 1,701 | $33k | 4.9% | Plan not stated | SEC |
| Apr 5, 2017 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 100,000 | $2.2M | 74.3% | Unusual | SEC |
| Feb 16, 2017 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 1,261 | $17k | 3.5% | Plan not stated | SEC |
| Nov 16, 2016 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 670 | $9k | 3.5% | Plan not stated | SEC |
| Aug 16, 2016 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 1,336 | $23k | 6.6% | Plan not stated | SEC |
| May 17, 2016 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 339 | $5k | 24.9% | Plan not stated | SEC |
| Feb 17, 2016 | NKTR | SVP & Chief Scientific Officer | Form 4 sale | 390 | $5k | 44.6% | Unusual | SEC |